Cargando…

Polypharmacy and medication use in patients with chronic kidney disease with and without kidney replacement therapy compared to matched controls

BACKGROUND: This study aims to examine polypharmacy (PP) prevalence in patients with chronic kidney disease (CKD) Stage G4/G5 and patients with kidney replacement therapy (KRT) compared with matched controls from the general population. Furthermore, we examine risk factors for PP and describe the mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Oosten, Manon J M, Logtenberg, Susan J J, Hemmelder, Marc H, Leegte, Martijn J H, Bilo, Henk J G, Jager, Kitty J, Stel, Vianda S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690067/ https://www.ncbi.nlm.nih.gov/pubmed/34950462 http://dx.doi.org/10.1093/ckj/sfab120

Ejemplares similares

Chronic prescription of antidepressant medication in patients with chronic kidney disease with and without kidney replacement therapy compared with matched controls in the Dutch general population
por: van Oosten, Manon J M, et al.
Publicado: (2021)

Age-related difference in health care use and costs of patients with chronic kidney disease and matched controls: analysis of Dutch health care claims data
por: van Oosten, Manon J M, et al.
Publicado: (2019)

Health claims databases used for kidney research around the world
por: van Oosten, Manon J M, et al.
Publicado: (2020)

The validity of Dutch health claims data for identifying patients with chronic kidney disease: a hospital-based study in the Netherlands
por: van Oosten, Manon J M, et al.
Publicado: (2020)

Healthcare costs of patients on different renal replacement modalities – Analysis of Dutch health insurance claims data
por: Mohnen, Sigrid M., et al.
Publicado: (2019)

Patient-reported factors influencing the choice of their kidney replacement treatment modality
por: de Jong, Rianne W, et al.
Publicado: (2021)

European nephrologists’ views on remote patient management for end-stage kidney disease
por: de Jong, Rianne W, et al.
Publicado: (2021)

Non-medical barriers reported by nephrologists when providing renal replacement therapy or comprehensive conservative management to end-stage kidney disease patients: a systematic review
por: de Jong, Rianne W, et al.
Publicado: (2020)

Incidence of renal replacement therapy for diabetic nephropathy in the Netherlands: Dutch diabetes estimates (DUDE)-3
por: van Dijk, Peter R, et al.
Publicado: (2015)

Work status and work ability of patients receiving kidney replacement therapy: results from a European survey
por: de Jong, Rianne W, et al.
Publicado: (2021)

Pregnancy after living kidney donation, a systematic review of the available evidence, and a review of the current guidance
por: Pippias, Maria, et al.
Publicado: (2022)

Translational research in nephrology: chronic kidney disease prevention and public health
por: Brück, Katharina, et al.
Publicado: (2015)

Factors influencing kidney transplantation rates: a study from the ERA Registry
por: Boenink, Rianne, et al.
Publicado: (2023)

The 2007 ERA-EDTA Registry Annual Report—a Précis
por: Stel, Vianda S., et al.
Publicado: (2009)

A new methodological series in CKJ: from basic-level methodology to artificial intelligence in medicine
por: Zoccali, Carmine, et al.
Publicado: (2023)

Inflammation, Endothelial Dysfunction and Increased Left Ventricular Mass in Chronic Kidney Disease (CKD) Patients: A Longitudinal Study
por: Ioannou, Kyriakos, et al.
Publicado: (2015)

Longitudinal association of body mass index and waist circumference with left ventricular mass in hypertensive predialysis chronic kidney disease patients
por: Stel, Vianda S., et al.
Publicado: (2013)

Results of the European EDITH nephrologist survey on factors influencing treatment modality choice for end-stage kidney disease
por: de Jong, Rianne W, et al.
Publicado: (2021)

Erratum to: Results of the European EDITH Nephrologist survey on factors influencing treatment modality choice for end-stage kidney disease
por: de Jong, Rianne W, et al.
Publicado: (2021)

The 2008 ERA–EDTA Registry Annual Report—a précis
por: Stel, Vianda S., et al.
Publicado: (2011)

Temporal trends in the quality of deceased donor kidneys and kidney transplant outcomes in Europe: an analysis by the ERA-EDTA Registry
por: Pippias, Maria, et al.
Publicado: (2021)

Translational research in nephrology: prognosis
por: Tripepi, Giovanni, et al.
Publicado: (2021)

Comment on: Bosi et al. Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. Diabetes Care 2013;36:2887–2894
por: Kleefstra, Nanne, et al.
Publicado: (2013)

The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease
por: Astley, Megan, et al.
Publicado: (2023)

Growth in children on kidney replacement therapy: a review of data from patient registries
por: Bonthuis, Marjolein, et al.
Publicado: (2021)

COVID-19 Pandemic Waves and Mortality Among Patients on Kidney Replacement Therapy
por: Vart, Priya, et al.
Publicado: (2022)

A snapshot of European registries on chronic kidney disease patients not on kidney replacement therapy
por: Jager, Kitty J, et al.
Publicado: (2021)

Competing risks analyses: objectives and approaches
por: Wolbers, Marcel, et al.
Publicado: (2014)

Where to look for the most frequent biases?
por: Jager, Kitty J., et al.
Publicado: (2020)

Points of attention when conducting etiological research
por: Stel, Vianda S., et al.
Publicado: (2021)

Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe
por: Jager, Kitty J., et al.
Publicado: (2020)

Increasing numbers and improved overall survival of patients on kidney replacement therapy over the last decade in Europe: an ERA Registry study
por: Huijben, Jilske A, et al.
Publicado: (2022)

The long-term benefits of early intensive therapy in chronic diseases—the legacy effect
por: Zoccali, Carmine, et al.
Publicado: (2023)

Evidence‐based medicine—When observational studies are better than randomized controlled trials
por: Bosdriesz, Jizzo R., et al.
Publicado: (2020)

An introduction to inverse probability of treatment weighting in observational research
por: Chesnaye, Nicholas C, et al.
Publicado: (2021)

Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes: A randomized controlled trial
por: Logtenberg, Susan J., et al.
Publicado: (2010)

Quality of Reporting and Study Design of CKD Cohort Studies Assessing Mortality in the Elderly Before and After STROBE: A Systematic Review
por: Rao, Anirudh, et al.
Publicado: (2016)

European chronic kidney disease registries for children not on kidney replacement therapy: tools for improving health systems and patient-centred outcomes
por: Bakkaloğlu, Sevcan A, et al.
Publicado: (2023)

Self-Monitoring of Blood Glucose: The Use of the First or the Second Drop of Blood
por: Hortensius, Johanna, et al.
Publicado: (2011)

Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: A randomized controlled trial
por: Logtenberg, Susan J., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_d6uv9a3k0e4it9s1agupncc47k